nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE2A—breast cancer	0.39	0.941	CbGaD
Dipyridamole—SLC29A1—Gemcitabine—breast cancer	0.0609	0.249	CbGbCtD
Dipyridamole—SLC29A1—Fluorouracil—breast cancer	0.0521	0.213	CbGbCtD
Dipyridamole—ABCC5—Fluorouracil—breast cancer	0.0398	0.163	CbGbCtD
Dipyridamole—ABCB1—breast cancer	0.0244	0.0589	CbGaD
Dipyridamole—ABCC4—Fluorouracil—breast cancer	0.0191	0.0783	CbGbCtD
Dipyridamole—ABCB1—Toremifene—breast cancer	0.0138	0.0564	CbGbCtD
Dipyridamole—ABCC4—Methotrexate—breast cancer	0.0105	0.0432	CbGbCtD
Dipyridamole—ABCB1—Lapatinib—breast cancer	0.0101	0.0411	CbGbCtD
Dipyridamole—ABCB1—Vinorelbine—breast cancer	0.00558	0.0228	CbGbCtD
Dipyridamole—ABCB1—Tamoxifen—breast cancer	0.00503	0.0206	CbGbCtD
Dipyridamole—ABCB1—Mitoxantrone—breast cancer	0.00491	0.0201	CbGbCtD
Dipyridamole—ABCB1—Gemcitabine—breast cancer	0.00434	0.0177	CbGbCtD
Dipyridamole—ABCB1—Paclitaxel—breast cancer	0.00392	0.016	CbGbCtD
Dipyridamole—ABCB1—Irinotecan—breast cancer	0.00386	0.0158	CbGbCtD
Dipyridamole—ABCB1—Vinblastine—breast cancer	0.00344	0.0141	CbGbCtD
Dipyridamole—ABCB1—Docetaxel—breast cancer	0.00283	0.0116	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—breast cancer	0.00211	0.00864	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—breast cancer	0.00205	0.00837	CbGbCtD
Dipyridamole—PDE6A—pituitary gland—breast cancer	0.00167	0.0254	CbGeAlD
Dipyridamole—PDE2A—mammary gland—breast cancer	0.00134	0.0204	CbGeAlD
Dipyridamole—PDE8A—mammary gland—breast cancer	0.00115	0.0175	CbGeAlD
Dipyridamole—PDE11A—epithelium—breast cancer	0.00115	0.0175	CbGeAlD
Dipyridamole—PDE2A—nipple—breast cancer	0.00111	0.0169	CbGeAlD
Dipyridamole—PRUNE—uterus—breast cancer	0.00107	0.0163	CbGeAlD
Dipyridamole—PRUNE—pituitary gland—breast cancer	0.00105	0.0161	CbGeAlD
Dipyridamole—PRUNE—adipose tissue—breast cancer	0.00105	0.016	CbGeAlD
Dipyridamole—PDE1C—adrenal gland—breast cancer	0.00104	0.0159	CbGeAlD
Dipyridamole—PDE6D—uterus—breast cancer	0.00104	0.0158	CbGeAlD
Dipyridamole—PDE6D—adipose tissue—breast cancer	0.00101	0.0154	CbGeAlD
Dipyridamole—PDE8A—nipple—breast cancer	0.000952	0.0145	CbGeAlD
Dipyridamole—PRUNE—adrenal gland—breast cancer	0.000942	0.0143	CbGeAlD
Dipyridamole—PDE6D—female reproductive system—breast cancer	0.000933	0.0142	CbGeAlD
Dipyridamole—PDE4A—mammary gland—breast cancer	0.000923	0.014	CbGeAlD
Dipyridamole—PDE6D—adrenal gland—breast cancer	0.00091	0.0139	CbGeAlD
Dipyridamole—PDE6B—adrenal gland—breast cancer	0.000895	0.0136	CbGeAlD
Dipyridamole—PDE6D—bone marrow—breast cancer	0.000881	0.0134	CbGeAlD
Dipyridamole—PRUNE—female gonad—breast cancer	0.000879	0.0134	CbGeAlD
Dipyridamole—PDE6D—female gonad—breast cancer	0.000849	0.0129	CbGeAlD
Dipyridamole—PDE11A—adrenal gland—breast cancer	0.000833	0.0127	CbGeAlD
Dipyridamole—PDE6G—adrenal gland—breast cancer	0.000801	0.0122	CbGeAlD
Dipyridamole—PDE7A—female reproductive system—breast cancer	0.00076	0.0116	CbGeAlD
Dipyridamole—PDE7B—adipose tissue—breast cancer	0.000723	0.011	CbGeAlD
Dipyridamole—PDE11A—endocrine gland—breast cancer	0.000722	0.011	CbGeAlD
Dipyridamole—PDE6H—endocrine gland—breast cancer	0.000722	0.011	CbGeAlD
Dipyridamole—ABCC5—mammary gland—breast cancer	0.000718	0.0109	CbGeAlD
Dipyridamole—PRUNE—Vincristine—Vinorelbine—breast cancer	0.000701	0.283	CbGdCrCtD
Dipyridamole—SLC29A1—mammary gland—breast cancer	0.000659	0.01	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vinblastine—breast cancer	0.000656	0.264	CbGdCrCtD
Dipyridamole—PDE7B—adrenal gland—breast cancer	0.000649	0.00987	CbGeAlD
Dipyridamole—PDE7A—endocrine gland—breast cancer	0.000643	0.00979	CbGeAlD
Dipyridamole—PDE1C—lymph node—breast cancer	0.000626	0.00953	CbGeAlD
Dipyridamole—PDE2A—uterus—breast cancer	0.000617	0.00939	CbGeAlD
Dipyridamole—PDE2A—pituitary gland—breast cancer	0.000606	0.00922	CbGeAlD
Dipyridamole—PDE10A—adipose tissue—breast cancer	0.000603	0.00918	CbGeAlD
Dipyridamole—PDE2A—adipose tissue—breast cancer	0.000603	0.00918	CbGeAlD
Dipyridamole—PDE1B—adipose tissue—breast cancer	0.000598	0.0091	CbGeAlD
Dipyridamole—PDE8B—uterus—breast cancer	0.000589	0.00896	CbGeAlD
Dipyridamole—PDE8B—adipose tissue—breast cancer	0.000576	0.00876	CbGeAlD
Dipyridamole—PDE8A—endometrium—breast cancer	0.000575	0.00874	CbGeAlD
Dipyridamole—PRUNE—lymph node—breast cancer	0.000565	0.0086	CbGeAlD
Dipyridamole—PDE3B—pituitary gland—breast cancer	0.000565	0.00859	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vinorelbine—breast cancer	0.000564	0.227	CbGdCrCtD
Dipyridamole—PDE3B—adipose tissue—breast cancer	0.000562	0.00856	CbGeAlD
Dipyridamole—PRUNE—Vincristine—Vinblastine—breast cancer	0.000561	0.226	CbGdCrCtD
Dipyridamole—PDE2A—female reproductive system—breast cancer	0.000555	0.00844	CbGeAlD
Dipyridamole—PDE1B—female reproductive system—breast cancer	0.00055	0.00837	CbGeAlD
Dipyridamole—PDE6D—lymph node—breast cancer	0.000546	0.0083	CbGeAlD
Dipyridamole—SLC29A1—nipple—breast cancer	0.000545	0.00829	CbGeAlD
Dipyridamole—PDE2A—adrenal gland—breast cancer	0.000541	0.00824	CbGeAlD
Dipyridamole—PDE10A—adrenal gland—breast cancer	0.000541	0.00824	CbGeAlD
Dipyridamole—PDE1B—adrenal gland—breast cancer	0.000536	0.00816	CbGeAlD
Dipyridamole—PDE8A—uterus—breast cancer	0.00053	0.00806	CbGeAlD
Dipyridamole—PDE8B—female reproductive system—breast cancer	0.000529	0.00805	CbGeAlD
Dipyridamole—PDE8A—pituitary gland—breast cancer	0.00052	0.00791	CbGeAlD
Dipyridamole—PDE8A—adipose tissue—breast cancer	0.000518	0.00788	CbGeAlD
Dipyridamole—PDE8B—adrenal gland—breast cancer	0.000516	0.00786	CbGeAlD
Dipyridamole—PDE1A—uterus—breast cancer	0.000512	0.0078	CbGeAlD
Dipyridamole—PDE10A—female gonad—breast cancer	0.000505	0.00768	CbGeAlD
Dipyridamole—PDE3B—adrenal gland—breast cancer	0.000504	0.00768	CbGeAlD
Dipyridamole—PDE1A—adipose tissue—breast cancer	0.000501	0.00763	CbGeAlD
Dipyridamole—PDE3B—bone marrow—breast cancer	0.000488	0.00743	CbGeAlD
Dipyridamole—PDE6G—lymph node—breast cancer	0.00048	0.00731	CbGeAlD
Dipyridamole—PDE2A—endocrine gland—breast cancer	0.000469	0.00714	CbGeAlD
Dipyridamole—PDE1B—endocrine gland—breast cancer	0.000465	0.00708	CbGeAlD
Dipyridamole—PDE8A—adrenal gland—breast cancer	0.000465	0.00707	CbGeAlD
Dipyridamole—PDE1A—female reproductive system—breast cancer	0.000461	0.00701	CbGeAlD
Dipyridamole—PDE1A—adrenal gland—breast cancer	0.00045	0.00684	CbGeAlD
Dipyridamole—PDE8B—endocrine gland—breast cancer	0.000448	0.00681	CbGeAlD
Dipyridamole—PDE3B—endocrine gland—breast cancer	0.000437	0.00666	CbGeAlD
Dipyridamole—PDE5A—epithelium—breast cancer	0.000437	0.00665	CbGeAlD
Dipyridamole—PDE8A—female gonad—breast cancer	0.000433	0.00659	CbGeAlD
Dipyridamole—ADA—adipose tissue—breast cancer	0.000426	0.00649	CbGeAlD
Dipyridamole—PDE1A—female gonad—breast cancer	0.000419	0.00638	CbGeAlD
Dipyridamole—PDE4A—adipose tissue—breast cancer	0.000415	0.00632	CbGeAlD
Dipyridamole—ADA—female reproductive system—breast cancer	0.000392	0.00596	CbGeAlD
Dipyridamole—PDE1A—endocrine gland—breast cancer	0.00039	0.00593	CbGeAlD
Dipyridamole—PDE7B—lymph node—breast cancer	0.000389	0.00592	CbGeAlD
Dipyridamole—ADA—adrenal gland—breast cancer	0.000382	0.00582	CbGeAlD
Dipyridamole—PDE4A—adrenal gland—breast cancer	0.000373	0.00567	CbGeAlD
Dipyridamole—ADA—bone marrow—breast cancer	0.00037	0.00563	CbGeAlD
Dipyridamole—PDE5A—adipose tissue—breast cancer	0.000353	0.00537	CbGeAlD
Dipyridamole—PDE4A—female gonad—breast cancer	0.000347	0.00529	CbGeAlD
Dipyridamole—PDE3A—adipose tissue—breast cancer	0.000344	0.00523	CbGeAlD
Dipyridamole—ADA—endocrine gland—breast cancer	0.000331	0.00504	CbGeAlD
Dipyridamole—SLC29A1—endometrium—breast cancer	0.000329	0.00501	CbGeAlD
Dipyridamole—PDE5A—female reproductive system—breast cancer	0.000325	0.00494	CbGeAlD
Dipyridamole—PDE2A—lymph node—breast cancer	0.000324	0.00494	CbGeAlD
Dipyridamole—PDE10A—lymph node—breast cancer	0.000324	0.00494	CbGeAlD
Dipyridamole—ABCC5—pituitary gland—breast cancer	0.000324	0.00494	CbGeAlD
Dipyridamole—ABCC5—adipose tissue—breast cancer	0.000323	0.00492	CbGeAlD
Dipyridamole—PDE1B—lymph node—breast cancer	0.000322	0.00489	CbGeAlD
Dipyridamole—PDE5A—adrenal gland—breast cancer	0.000317	0.00482	CbGeAlD
Dipyridamole—PDE3A—female reproductive system—breast cancer	0.000316	0.00481	CbGeAlD
Dipyridamole—PDE8B—lymph node—breast cancer	0.00031	0.00471	CbGeAlD
Dipyridamole—PDE3A—adrenal gland—breast cancer	0.000308	0.00469	CbGeAlD
Dipyridamole—SLC29A1—uterus—breast cancer	0.000303	0.00461	CbGeAlD
Dipyridamole—PDE3B—lymph node—breast cancer	0.000302	0.0046	CbGeAlD
Dipyridamole—SLC29A1—pituitary gland—breast cancer	0.000298	0.00453	CbGeAlD
Dipyridamole—SLC29A1—adipose tissue—breast cancer	0.000297	0.00451	CbGeAlD
Dipyridamole—PDE5A—female gonad—breast cancer	0.000295	0.00449	CbGeAlD
Dipyridamole—ABCC5—adrenal gland—breast cancer	0.00029	0.00441	CbGeAlD
Dipyridamole—PDE3A—female gonad—breast cancer	0.000287	0.00437	CbGeAlD
Dipyridamole—ABCC5—bone marrow—breast cancer	0.00028	0.00427	CbGeAlD
Dipyridamole—PDE8A—lymph node—breast cancer	0.000278	0.00424	CbGeAlD
Dipyridamole—PDE5A—endocrine gland—breast cancer	0.000275	0.00418	CbGeAlD
Dipyridamole—SLC29A1—female reproductive system—breast cancer	0.000273	0.00415	CbGeAlD
Dipyridamole—ABCC5—female gonad—breast cancer	0.00027	0.00411	CbGeAlD
Dipyridamole—PDE1A—lymph node—breast cancer	0.000269	0.0041	CbGeAlD
Dipyridamole—PDE3A—endocrine gland—breast cancer	0.000267	0.00407	CbGeAlD
Dipyridamole—SLC29A1—adrenal gland—breast cancer	0.000266	0.00405	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—breast cancer	0.000257	0.00392	CbGeAlD
Dipyridamole—SLC29A1—female gonad—breast cancer	0.000248	0.00377	CbGeAlD
Dipyridamole—SLC29A1—endocrine gland—breast cancer	0.000231	0.00351	CbGeAlD
Dipyridamole—ADA—lymph node—breast cancer	0.000229	0.00349	CbGeAlD
Dipyridamole—ABCC4—uterus—breast cancer	0.000229	0.00348	CbGeAlD
Dipyridamole—ABCC4—adipose tissue—breast cancer	0.000224	0.00341	CbGeAlD
Dipyridamole—PDE4A—lymph node—breast cancer	0.000223	0.0034	CbGeAlD
Dipyridamole—ABCC4—female reproductive system—breast cancer	0.000206	0.00313	CbGeAlD
Dipyridamole—ABCC4—adrenal gland—breast cancer	0.000201	0.00306	CbGeAlD
Dipyridamole—ABCC4—bone marrow—breast cancer	0.000194	0.00296	CbGeAlD
Dipyridamole—PDE5A—lymph node—breast cancer	0.00019	0.00289	CbGeAlD
Dipyridamole—ABCC4—female gonad—breast cancer	0.000187	0.00285	CbGeAlD
Dipyridamole—PDE3A—lymph node—breast cancer	0.000185	0.00281	CbGeAlD
Dipyridamole—ABCC4—endocrine gland—breast cancer	0.000174	0.00265	CbGeAlD
Dipyridamole—ABCC5—lymph node—breast cancer	0.000174	0.00264	CbGeAlD
Dipyridamole—SLC29A1—lymph node—breast cancer	0.000159	0.00243	CbGeAlD
Dipyridamole—ABCC4—lymph node—breast cancer	0.00012	0.00183	CbGeAlD
Dipyridamole—ABCB1—embryo—breast cancer	0.000118	0.0018	CbGeAlD
Dipyridamole—ABCB1—epithelium—breast cancer	9.64e-05	0.00147	CbGeAlD
Dipyridamole—ABCB1—endometrium—breast cancer	8.65e-05	0.00132	CbGeAlD
Dipyridamole—ABCB1—uterus—breast cancer	7.97e-05	0.00121	CbGeAlD
Dipyridamole—ABCB1—pituitary gland—breast cancer	7.82e-05	0.00119	CbGeAlD
Dipyridamole—ABCB1—adipose tissue—breast cancer	7.79e-05	0.00119	CbGeAlD
Dipyridamole—ABCB1—female reproductive system—breast cancer	7.16e-05	0.00109	CbGeAlD
Dipyridamole—ABCB1—adrenal gland—breast cancer	6.99e-05	0.00106	CbGeAlD
Dipyridamole—ABCB1—bone marrow—breast cancer	6.76e-05	0.00103	CbGeAlD
Dipyridamole—ABCB1—female gonad—breast cancer	6.52e-05	0.000992	CbGeAlD
Dipyridamole—ABCB1—endocrine gland—breast cancer	6.06e-05	0.000922	CbGeAlD
Dipyridamole—ABCB1—lymph node—breast cancer	4.19e-05	0.000638	CbGeAlD
Dipyridamole—Immune system disorder—Methotrexate—breast cancer	3.14e-05	0.000224	CcSEcCtD
Dipyridamole—Dizziness—Fluorouracil—breast cancer	3.14e-05	0.000224	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—breast cancer	3.13e-05	0.000224	CcSEcCtD
Dipyridamole—Rash—Irinotecan—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Rash—Mitoxantrone—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Dermatitis—Mitoxantrone—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Dermatitis—Irinotecan—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Docetaxel—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Chills—Methotrexate—breast cancer	3.12e-05	0.000223	CcSEcCtD
Dipyridamole—Headache—Irinotecan—breast cancer	3.1e-05	0.000222	CcSEcCtD
Dipyridamole—Headache—Mitoxantrone—breast cancer	3.1e-05	0.000222	CcSEcCtD
Dipyridamole—Hypotension—Capecitabine—breast cancer	3.1e-05	0.000221	CcSEcCtD
Dipyridamole—Paraesthesia—Docetaxel—breast cancer	3.07e-05	0.00022	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—breast cancer	3.07e-05	0.000219	CcSEcCtD
Dipyridamole—Vomiting—Gemcitabine—breast cancer	3.07e-05	0.000219	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—breast cancer	3.06e-05	0.000219	CcSEcCtD
Dipyridamole—Dyspnoea—Docetaxel—breast cancer	3.05e-05	0.000218	CcSEcCtD
Dipyridamole—Somnolence—Docetaxel—breast cancer	3.04e-05	0.000217	CcSEcCtD
Dipyridamole—Rash—Gemcitabine—breast cancer	3.04e-05	0.000217	CcSEcCtD
Dipyridamole—Dermatitis—Gemcitabine—breast cancer	3.04e-05	0.000217	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—breast cancer	3.03e-05	0.000216	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—breast cancer	3.02e-05	0.000216	CcSEcCtD
Dipyridamole—Headache—Gemcitabine—breast cancer	3.02e-05	0.000216	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Capecitabine—breast cancer	3.02e-05	0.000216	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—breast cancer	3.02e-05	0.000215	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—breast cancer	3.02e-05	0.000215	CcSEcCtD
Dipyridamole—Vomiting—Fluorouracil—breast cancer	3.02e-05	0.000215	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—breast cancer	3.01e-05	0.000215	CcSEcCtD
Dipyridamole—Dyspepsia—Docetaxel—breast cancer	3.01e-05	0.000215	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—breast cancer	3.01e-05	0.000215	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—breast cancer	3.01e-05	0.000215	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—breast cancer	2.99e-05	0.000214	CcSEcCtD
Dipyridamole—Rash—Fluorouracil—breast cancer	2.99e-05	0.000214	CcSEcCtD
Dipyridamole—Dermatitis—Fluorouracil—breast cancer	2.99e-05	0.000213	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—breast cancer	2.98e-05	0.000213	CcSEcCtD
Dipyridamole—Paraesthesia—Capecitabine—breast cancer	2.98e-05	0.000213	CcSEcCtD
Dipyridamole—Hypersensitivity—Paclitaxel—breast cancer	2.98e-05	0.000213	CcSEcCtD
Dipyridamole—Headache—Fluorouracil—breast cancer	2.97e-05	0.000212	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—breast cancer	2.96e-05	0.000211	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Docetaxel—breast cancer	2.96e-05	0.000211	CcSEcCtD
Dipyridamole—Dyspnoea—Capecitabine—breast cancer	2.96e-05	0.000211	CcSEcCtD
Dipyridamole—Fatigue—Docetaxel—breast cancer	2.95e-05	0.000211	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—breast cancer	2.95e-05	0.000211	CcSEcCtD
Dipyridamole—Nausea—Mitoxantrone—breast cancer	2.94e-05	0.00021	CcSEcCtD
Dipyridamole—Nausea—Irinotecan—breast cancer	2.94e-05	0.00021	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—breast cancer	2.94e-05	0.00021	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—breast cancer	2.93e-05	0.000209	CcSEcCtD
Dipyridamole—Pain—Docetaxel—breast cancer	2.93e-05	0.000209	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—breast cancer	2.92e-05	0.000209	CcSEcCtD
Dipyridamole—Dyspepsia—Capecitabine—breast cancer	2.92e-05	0.000208	CcSEcCtD
Dipyridamole—Chills—Epirubicin—breast cancer	2.92e-05	0.000208	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—breast cancer	2.9e-05	0.000207	CcSEcCtD
Dipyridamole—Asthenia—Paclitaxel—breast cancer	2.9e-05	0.000207	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—breast cancer	2.87e-05	0.000205	CcSEcCtD
Dipyridamole—Nausea—Gemcitabine—breast cancer	2.87e-05	0.000205	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Capecitabine—breast cancer	2.86e-05	0.000204	CcSEcCtD
Dipyridamole—Fatigue—Capecitabine—breast cancer	2.86e-05	0.000204	CcSEcCtD
Dipyridamole—Pruritus—Paclitaxel—breast cancer	2.86e-05	0.000204	CcSEcCtD
Dipyridamole—Pain—Capecitabine—breast cancer	2.83e-05	0.000202	CcSEcCtD
Dipyridamole—Feeling abnormal—Docetaxel—breast cancer	2.82e-05	0.000201	CcSEcCtD
Dipyridamole—Nausea—Fluorouracil—breast cancer	2.82e-05	0.000201	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—breast cancer	2.81e-05	0.0002	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—breast cancer	2.8e-05	0.0002	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Docetaxel—breast cancer	2.8e-05	0.0002	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—breast cancer	2.79e-05	0.0002	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—breast cancer	2.79e-05	0.000199	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—breast cancer	2.79e-05	0.000199	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—breast cancer	2.79e-05	0.000199	CcSEcCtD
Dipyridamole—Tension—Epirubicin—breast cancer	2.78e-05	0.000198	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—breast cancer	2.77e-05	0.000198	CcSEcCtD
Dipyridamole—Diarrhoea—Paclitaxel—breast cancer	2.76e-05	0.000197	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—breast cancer	2.75e-05	0.000196	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—breast cancer	2.74e-05	0.000195	CcSEcCtD
Dipyridamole—Feeling abnormal—Capecitabine—breast cancer	2.73e-05	0.000195	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—breast cancer	2.73e-05	0.000195	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—breast cancer	2.73e-05	0.000195	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—breast cancer	2.72e-05	0.000194	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—breast cancer	2.72e-05	0.000194	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—breast cancer	2.72e-05	0.000194	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Capecitabine—breast cancer	2.71e-05	0.000194	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—breast cancer	2.71e-05	0.000194	CcSEcCtD
Dipyridamole—Abdominal pain—Docetaxel—breast cancer	2.71e-05	0.000193	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—breast cancer	2.7e-05	0.000193	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—breast cancer	2.69e-05	0.000192	CcSEcCtD
Dipyridamole—Dizziness—Paclitaxel—breast cancer	2.67e-05	0.000191	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—breast cancer	2.66e-05	0.00019	CcSEcCtD
Dipyridamole—Cough—Methotrexate—breast cancer	2.64e-05	0.000188	CcSEcCtD
Dipyridamole—Urticaria—Capecitabine—breast cancer	2.63e-05	0.000188	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—breast cancer	2.63e-05	0.000187	CcSEcCtD
Dipyridamole—Abdominal pain—Capecitabine—breast cancer	2.62e-05	0.000187	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—breast cancer	2.62e-05	0.000187	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—breast cancer	2.62e-05	0.000187	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—breast cancer	2.58e-05	0.000184	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—breast cancer	2.57e-05	0.000184	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—breast cancer	2.57e-05	0.000184	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—breast cancer	2.57e-05	0.000184	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—breast cancer	2.57e-05	0.000183	CcSEcCtD
Dipyridamole—Vomiting—Paclitaxel—breast cancer	2.57e-05	0.000183	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—breast cancer	2.56e-05	0.000183	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.56e-05	0.000183	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—breast cancer	2.55e-05	0.000182	CcSEcCtD
Dipyridamole—Rash—Paclitaxel—breast cancer	2.55e-05	0.000182	CcSEcCtD
Dipyridamole—Dermatitis—Paclitaxel—breast cancer	2.54e-05	0.000182	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—breast cancer	2.54e-05	0.000182	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—breast cancer	2.54e-05	0.000182	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—breast cancer	2.54e-05	0.000182	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—breast cancer	2.54e-05	0.000181	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—breast cancer	2.53e-05	0.000181	CcSEcCtD
Dipyridamole—Headache—Paclitaxel—breast cancer	2.53e-05	0.000181	CcSEcCtD
Dipyridamole—Hypersensitivity—Docetaxel—breast cancer	2.52e-05	0.00018	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—breast cancer	2.52e-05	0.00018	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—breast cancer	2.5e-05	0.000179	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—breast cancer	2.49e-05	0.000178	CcSEcCtD
Dipyridamole—Cough—Epirubicin—breast cancer	2.47e-05	0.000176	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—breast cancer	2.47e-05	0.000176	CcSEcCtD
Dipyridamole—Asthenia—Docetaxel—breast cancer	2.46e-05	0.000175	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—breast cancer	2.45e-05	0.000175	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—breast cancer	2.44e-05	0.000174	CcSEcCtD
Dipyridamole—Hypersensitivity—Capecitabine—breast cancer	2.44e-05	0.000174	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—breast cancer	2.43e-05	0.000173	CcSEcCtD
Dipyridamole—Pruritus—Docetaxel—breast cancer	2.42e-05	0.000173	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—breast cancer	2.42e-05	0.000173	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—breast cancer	2.42e-05	0.000173	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—breast cancer	2.42e-05	0.000173	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—breast cancer	2.41e-05	0.000172	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—breast cancer	2.41e-05	0.000172	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—breast cancer	2.41e-05	0.000172	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—breast cancer	2.4e-05	0.000171	CcSEcCtD
Dipyridamole—Nausea—Paclitaxel—breast cancer	2.4e-05	0.000171	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—breast cancer	2.4e-05	0.000171	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.39e-05	0.000171	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—breast cancer	2.39e-05	0.00017	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—breast cancer	2.38e-05	0.00017	CcSEcCtD
Dipyridamole—Asthenia—Capecitabine—breast cancer	2.38e-05	0.00017	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—breast cancer	2.36e-05	0.000169	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—breast cancer	2.36e-05	0.000168	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—breast cancer	2.35e-05	0.000168	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—breast cancer	2.35e-05	0.000168	CcSEcCtD
Dipyridamole—Pruritus—Capecitabine—breast cancer	2.35e-05	0.000167	CcSEcCtD
Dipyridamole—Diarrhoea—Docetaxel—breast cancer	2.34e-05	0.000167	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—breast cancer	2.31e-05	0.000165	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—breast cancer	2.31e-05	0.000165	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—breast cancer	2.31e-05	0.000165	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—breast cancer	2.31e-05	0.000165	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—breast cancer	2.3e-05	0.000164	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—breast cancer	2.28e-05	0.000163	CcSEcCtD
Dipyridamole—Shock—Epirubicin—breast cancer	2.27e-05	0.000162	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—breast cancer	2.27e-05	0.000162	CcSEcCtD
Dipyridamole—Diarrhoea—Capecitabine—breast cancer	2.27e-05	0.000162	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—breast cancer	2.26e-05	0.000162	CcSEcCtD
Dipyridamole—Dizziness—Docetaxel—breast cancer	2.26e-05	0.000162	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—breast cancer	2.26e-05	0.000161	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—breast cancer	2.26e-05	0.000161	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—breast cancer	2.25e-05	0.000161	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—breast cancer	2.25e-05	0.000161	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—breast cancer	2.24e-05	0.00016	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—breast cancer	2.23e-05	0.000159	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—breast cancer	2.23e-05	0.000159	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—breast cancer	2.23e-05	0.000159	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—breast cancer	2.23e-05	0.000159	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—breast cancer	2.22e-05	0.000159	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—breast cancer	2.22e-05	0.000158	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.21e-05	0.000158	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—breast cancer	2.2e-05	0.000157	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—breast cancer	2.2e-05	0.000157	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—breast cancer	2.19e-05	0.000157	CcSEcCtD
Dipyridamole—Dizziness—Capecitabine—breast cancer	2.19e-05	0.000157	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—breast cancer	2.18e-05	0.000156	CcSEcCtD
Dipyridamole—Vomiting—Docetaxel—breast cancer	2.18e-05	0.000155	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—breast cancer	2.17e-05	0.000155	CcSEcCtD
Dipyridamole—Rash—Docetaxel—breast cancer	2.16e-05	0.000154	CcSEcCtD
Dipyridamole—Hypotension—Epirubicin—breast cancer	2.16e-05	0.000154	CcSEcCtD
Dipyridamole—Dermatitis—Docetaxel—breast cancer	2.16e-05	0.000154	CcSEcCtD
Dipyridamole—Headache—Docetaxel—breast cancer	2.14e-05	0.000153	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—breast cancer	2.14e-05	0.000153	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—breast cancer	2.14e-05	0.000153	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—breast cancer	2.13e-05	0.000152	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—breast cancer	2.13e-05	0.000152	CcSEcCtD
Dipyridamole—Pain—Methotrexate—breast cancer	2.11e-05	0.000151	CcSEcCtD
Dipyridamole—Vomiting—Capecitabine—breast cancer	2.11e-05	0.000151	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—breast cancer	2.1e-05	0.00015	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—breast cancer	2.1e-05	0.00015	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—breast cancer	2.1e-05	0.00015	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—breast cancer	2.09e-05	0.000149	CcSEcCtD
Dipyridamole—Rash—Capecitabine—breast cancer	2.09e-05	0.000149	CcSEcCtD
Dipyridamole—Dermatitis—Capecitabine—breast cancer	2.09e-05	0.000149	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—breast cancer	2.09e-05	0.000149	CcSEcCtD
Dipyridamole—Headache—Capecitabine—breast cancer	2.08e-05	0.000148	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—breast cancer	2.08e-05	0.000148	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—breast cancer	2.07e-05	0.000148	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—breast cancer	2.07e-05	0.000148	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—breast cancer	2.06e-05	0.000147	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—breast cancer	2.05e-05	0.000147	CcSEcCtD
Dipyridamole—Nausea—Docetaxel—breast cancer	2.03e-05	0.000145	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—breast cancer	2.03e-05	0.000145	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—breast cancer	2.03e-05	0.000145	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—breast cancer	2.02e-05	0.000144	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—breast cancer	2e-05	0.000143	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—breast cancer	1.99e-05	0.000142	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—breast cancer	1.99e-05	0.000142	CcSEcCtD
Dipyridamole—Pain—Epirubicin—breast cancer	1.97e-05	0.000141	CcSEcCtD
Dipyridamole—Nausea—Capecitabine—breast cancer	1.97e-05	0.000141	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—breast cancer	1.96e-05	0.00014	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—breast cancer	1.95e-05	0.000139	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.95e-05	0.000139	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—breast cancer	1.92e-05	0.000137	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—breast cancer	1.9e-05	0.000136	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—breast cancer	1.9e-05	0.000136	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—breast cancer	1.9e-05	0.000136	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—breast cancer	1.89e-05	0.000135	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—breast cancer	1.88e-05	0.000134	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—breast cancer	1.84e-05	0.000132	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—breast cancer	1.84e-05	0.000132	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—breast cancer	1.83e-05	0.000131	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—breast cancer	1.83e-05	0.00013	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—breast cancer	1.83e-05	0.00013	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—breast cancer	1.82e-05	0.00013	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—breast cancer	1.77e-05	0.000126	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—breast cancer	1.76e-05	0.000126	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—breast cancer	1.75e-05	0.000125	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—breast cancer	1.75e-05	0.000125	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—breast cancer	1.7e-05	0.000122	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—breast cancer	1.7e-05	0.000121	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—breast cancer	1.69e-05	0.000121	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—breast cancer	1.69e-05	0.000121	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—breast cancer	1.66e-05	0.000118	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—breast cancer	1.63e-05	0.000117	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—breast cancer	1.63e-05	0.000117	CcSEcCtD
Dipyridamole—Diarrhoea—Epirubicin—breast cancer	1.58e-05	0.000113	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—breast cancer	1.57e-05	0.000112	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—breast cancer	1.57e-05	0.000112	CcSEcCtD
Dipyridamole—Rash—Methotrexate—breast cancer	1.56e-05	0.000111	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—breast cancer	1.55e-05	0.000111	CcSEcCtD
Dipyridamole—Headache—Methotrexate—breast cancer	1.55e-05	0.00011	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—breast cancer	1.53e-05	0.000109	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—breast cancer	1.53e-05	0.000109	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—breast cancer	1.51e-05	0.000108	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—breast cancer	1.47e-05	0.000105	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—breast cancer	1.47e-05	0.000105	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—breast cancer	1.46e-05	0.000104	CcSEcCtD
Dipyridamole—Rash—Epirubicin—breast cancer	1.46e-05	0.000104	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Dipyridamole—Headache—Epirubicin—breast cancer	1.45e-05	0.000103	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—breast cancer	1.41e-05	0.000101	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—breast cancer	1.37e-05	9.8e-05	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—breast cancer	1.36e-05	9.7e-05	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—breast cancer	1.35e-05	9.62e-05	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—breast cancer	1.35e-05	9.61e-05	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—breast cancer	1.34e-05	9.56e-05	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—breast cancer	1.27e-05	9.06e-05	CcSEcCtD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—breast cancer	1.52e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTEN—breast cancer	1.52e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—breast cancer	1.52e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—breast cancer	1.51e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—breast cancer	1.51e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—breast cancer	1.51e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1B—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MED12—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DPYD—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RAF1—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—breast cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—breast cancer	1.5e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RELA—breast cancer	1.5e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—breast cancer	1.5e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—breast cancer	1.5e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—breast cancer	1.5e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1A—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDOA—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTEN—breast cancer	1.49e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—breast cancer	1.48e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—breast cancer	1.48e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—breast cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—breast cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—breast cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—breast cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—breast cancer	1.48e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MTOR—breast cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CB—breast cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—breast cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—breast cancer	1.47e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1B—breast cancer	1.47e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—breast cancer	1.46e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—breast cancer	1.46e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—breast cancer	1.45e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK8—breast cancer	1.45e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—breast cancer	1.45e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA3—breast cancer	1.44e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—breast cancer	1.44e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—breast cancer	1.44e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—breast cancer	1.44e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—breast cancer	1.44e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—breast cancer	1.43e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A2—breast cancer	1.43e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—breast cancer	1.43e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—breast cancer	1.43e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAPK3—breast cancer	1.42e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—breast cancer	1.41e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—breast cancer	1.41e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CPT1A—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTR—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ABCG2—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—breast cancer	1.4e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1A—breast cancer	1.39e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTEN—breast cancer	1.39e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—breast cancer	1.39e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—breast cancer	1.39e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—breast cancer	1.39e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1B—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RAF1—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—breast cancer	1.38e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—breast cancer	1.38e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HPGDS—breast cancer	1.38e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—breast cancer	1.38e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RELA—breast cancer	1.37e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA1—breast cancer	1.37e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—breast cancer	1.37e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—breast cancer	1.36e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—breast cancer	1.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK8—breast cancer	1.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—breast cancer	1.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—breast cancer	1.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1A—breast cancer	1.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—breast cancer	1.35e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTEN—breast cancer	1.35e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—breast cancer	1.35e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—breast cancer	1.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CB—breast cancer	1.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MTOR—breast cancer	1.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—breast cancer	1.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—breast cancer	1.34e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—breast cancer	1.34e-06	1e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ACHE—breast cancer	1.34e-06	1e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—breast cancer	1.33e-06	9.98e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK8—breast cancer	1.32e-06	9.94e-06	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—breast cancer	1.32e-06	9.94e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—breast cancer	1.32e-06	9.92e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—breast cancer	1.32e-06	9.9e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—breast cancer	1.32e-06	9.88e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—breast cancer	1.31e-06	9.81e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.3e-06	9.73e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—breast cancer	1.29e-06	9.72e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—breast cancer	1.29e-06	9.69e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—breast cancer	1.29e-06	9.66e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—breast cancer	1.28e-06	9.65e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—breast cancer	1.28e-06	9.63e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—breast cancer	1.28e-06	9.63e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—breast cancer	1.28e-06	9.61e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—breast cancer	1.28e-06	9.58e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1A—breast cancer	1.28e-06	9.58e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTEN—breast cancer	1.27e-06	9.56e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—breast cancer	1.27e-06	9.54e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK3—breast cancer	1.27e-06	9.54e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP17A1—breast cancer	1.26e-06	9.49e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1B—breast cancer	1.26e-06	9.49e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—breast cancer	1.26e-06	9.44e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—breast cancer	1.26e-06	9.43e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO1—breast cancer	1.25e-06	9.4e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS1—breast cancer	1.25e-06	9.4e-06	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—breast cancer	1.25e-06	9.39e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK8—breast cancer	1.24e-06	9.35e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—breast cancer	1.24e-06	9.35e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—breast cancer	1.24e-06	9.32e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—breast cancer	1.24e-06	9.3e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—breast cancer	1.24e-06	9.29e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—breast cancer	1.23e-06	9.27e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—breast cancer	1.23e-06	9.25e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—breast cancer	1.23e-06	9.24e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—breast cancer	1.23e-06	9.23e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2D6—breast cancer	1.23e-06	9.22e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—breast cancer	1.22e-06	9.18e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—breast cancer	1.21e-06	9.09e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—breast cancer	1.21e-06	9.07e-06	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—breast cancer	1.21e-06	9.07e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—breast cancer	1.21e-06	9.06e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA2—breast cancer	1.2e-06	9.05e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—breast cancer	1.2e-06	9.04e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—breast cancer	1.19e-06	8.97e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK3—breast cancer	1.19e-06	8.93e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—breast cancer	1.19e-06	8.91e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—breast cancer	1.19e-06	8.91e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—breast cancer	1.18e-06	8.86e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—breast cancer	1.17e-06	8.82e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—breast cancer	1.17e-06	8.81e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—breast cancer	1.17e-06	8.79e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.17e-06	8.79e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FASN—breast cancer	1.17e-06	8.77e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1A—breast cancer	1.17e-06	8.76e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTEN—breast cancer	1.16e-06	8.74e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—breast cancer	1.16e-06	8.74e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK3—breast cancer	1.16e-06	8.69e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—breast cancer	1.16e-06	8.68e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—breast cancer	1.15e-06	8.66e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—breast cancer	1.15e-06	8.63e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC5A5—breast cancer	1.15e-06	8.63e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—breast cancer	1.14e-06	8.57e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK8—breast cancer	1.14e-06	8.55e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—breast cancer	1.14e-06	8.55e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—breast cancer	1.14e-06	8.53e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—breast cancer	1.14e-06	8.53e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—breast cancer	1.14e-06	8.53e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—breast cancer	1.13e-06	8.52e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—breast cancer	1.13e-06	8.49e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—breast cancer	1.12e-06	8.45e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—breast cancer	1.12e-06	8.45e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—breast cancer	1.12e-06	8.43e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A1—breast cancer	1.11e-06	8.34e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NQO1—breast cancer	1.11e-06	8.34e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—breast cancer	1.1e-06	8.26e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK3—breast cancer	1.09e-06	8.17e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—breast cancer	1.08e-06	8.15e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP3A4—breast cancer	1.08e-06	8.13e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—breast cancer	1.08e-06	8.11e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—breast cancer	1.07e-06	8.06e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—breast cancer	1.07e-06	8.02e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1B1—breast cancer	1.06e-06	7.99e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.06e-06	7.95e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—breast cancer	1.06e-06	7.94e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—breast cancer	1.05e-06	7.92e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—breast cancer	1.05e-06	7.9e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—breast cancer	1.05e-06	7.87e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—breast cancer	1.05e-06	7.87e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—breast cancer	1.05e-06	7.87e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HSP90AA1—breast cancer	1.04e-06	7.84e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—breast cancer	1.04e-06	7.82e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—breast cancer	1.04e-06	7.81e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—breast cancer	1.04e-06	7.8e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—breast cancer	1.04e-06	7.79e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—breast cancer	1.03e-06	7.77e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA1—breast cancer	1.01e-06	7.62e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—breast cancer	1.01e-06	7.62e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—STK11—breast cancer	1e-06	7.51e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP19A1—breast cancer	1e-06	7.51e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK3—breast cancer	9.94e-07	7.47e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—breast cancer	9.81e-07	7.37e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—breast cancer	9.77e-07	7.34e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—breast cancer	9.7e-07	7.28e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—breast cancer	9.67e-07	7.26e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—breast cancer	9.65e-07	7.25e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—breast cancer	9.58e-07	7.19e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—breast cancer	9.55e-07	7.17e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—breast cancer	9.49e-07	7.13e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—breast cancer	9.46e-07	7.11e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—COMT—breast cancer	9.3e-07	6.99e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—breast cancer	9.28e-07	6.97e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—breast cancer	9.26e-07	6.95e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—breast cancer	9.24e-07	6.94e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—breast cancer	9.13e-07	6.86e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ITPR1—breast cancer	9.11e-07	6.84e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—breast cancer	9.08e-07	6.82e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—breast cancer	8.98e-07	6.74e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—breast cancer	8.94e-07	6.71e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—breast cancer	8.83e-07	6.63e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—breast cancer	8.77e-07	6.59e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—breast cancer	8.69e-07	6.53e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—breast cancer	8.68e-07	6.52e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TYMS—breast cancer	8.6e-07	6.46e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—breast cancer	8.56e-07	6.43e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOR1—breast cancer	8.51e-07	6.39e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLA2G4A—breast cancer	8.51e-07	6.39e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTM1—breast cancer	8.51e-07	6.39e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—breast cancer	8.45e-07	6.35e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—breast cancer	8.3e-07	6.24e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—breast cancer	8.21e-07	6.17e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—breast cancer	8.15e-07	6.12e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1A1—breast cancer	8.06e-07	6.06e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—breast cancer	8.02e-07	6.02e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ERCC2—breast cancer	8e-07	6.01e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—breast cancer	7.95e-07	5.97e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—breast cancer	7.94e-07	5.97e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—breast cancer	7.8e-07	5.86e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—breast cancer	7.6e-07	5.71e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—breast cancer	7.52e-07	5.65e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—breast cancer	7.33e-07	5.51e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—breast cancer	7.27e-07	5.46e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAV1—breast cancer	6.93e-07	5.21e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—breast cancer	6.71e-07	5.04e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CG—breast cancer	6.32e-07	4.74e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CD—breast cancer	5.55e-07	4.17e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—breast cancer	5.48e-07	4.12e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—breast cancer	5.24e-07	3.94e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CB—breast cancer	4.84e-07	3.64e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—breast cancer	4.8e-07	3.6e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTEN—breast cancer	4.18e-07	3.14e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—breast cancer	2.95e-07	2.22e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—breast cancer	2.41e-07	1.81e-06	CbGpPWpGaD
